NIR Light May Trigger Brain-Protective Melatonin Inside Mitochondria

The human brain accounts for roughly 20% of the body's total energy expenditure despite representing only 2% of body mass. Neurons operate near metabolic capacity, generating substantial reactive oxygen species (ROS) as obligate byproducts, yet paradoxically maintain lower baseline antioxidant reserves than most other tissues. Neuronal membranes are enriched with polyunsaturated fatty acids susceptible to lipid peroxidation, and mitochondrial DNA lacks the protective histones present in nuclear DNA, making it especially vulnerable to cumulative oxidative damage. This metabolic precarity is compounded by age-related declines in pineal melatonin—potentially falling to less than 20% of young-adult levels by late life—and progressive mitochondrial dysfunction, both of which are strongly implicated in Alzheimer's disease pathogenesis.

This paper synthesizes evidence across photobiomodulation (PBM) research, mitochondrial biology, and melatonin biochemistry to propose a mechanistic cascade: NIR radiation (620–1100 nm), absorbed by cytochrome c oxidase (CCO) in mitochondria, may stimulate local melatonin synthesis via the enzyme machinery (AANAT and ASMT) now known to reside in mitochondria. Unlike pineal melatonin, this extrapineal synthesis lacks circadian rhythmicity and may produce local concentrations up to 100-fold higher than plasma levels. The resulting melatonin could then upregulate glutathione-synthesizing enzymes and activate SIRT3-mediated superoxide dismutase 2 (SOD2), creating a multi-layered antioxidant response concentrated at the site of highest ROS production.

A critical and often overlooked element of the proposed cascade is substrate availability. Glutathione synthesis requires adequate glycine and cysteine, both of which decline with age. Glycine is now recognized as conditionally essential, with endogenous synthesis insufficient to meet full metabolic demands in older adults. The paper argues that NIR-stimulated enzyme upregulation is futile without these precursors, identifying glycine and N-acetylcysteine (NAC) supplementation as potentially rate-limiting co-interventions. Evidence for each step of the cascade was catalogued using a four-tier strength hierarchy, distinguishing well-established findings from speculative predictions.

The literature synthesis drew on 104 peer-reviewed articles from PubMed, Web of Science, and Google Scholar (1990–2025), prioritizing mechanistic studies, randomized controlled trials, and systematic reviews. The author explicitly frames this as a narrative hypothesis paper rather than a systematic review, acknowledging that while individual components are well-supported, the integrated NIR→CCO→mitochondrial melatonin→glutathione→neuroprotection cascade has not been validated as a unified system in humans.

The paper's clinical implications center on photobiomodulation therapy (transcranial NIR delivery) as a potentially modifiable environmental intervention for neuroprotection, particularly relevant given the near-total absence of NIR in modern indoor lighting. However, cautions are warranted: no epidemiological evidence directly links reduced sunlight NIR exposure to increased neurodegeneration risk, the melatonin-Alzheimer's relationship may reflect consequence rather than cause, and optimal dosing parameters for transcranial PBM remain under investigation.